Enrolling Clinical Research Studies
Cardiovascular
Type 2 Diabetes, Hypertension and established Cardiovascular Disease
Type 2 Diabetes and Cardiovascular Risk
Type 2 Diabetes and Cardiovascular Risk
Diabetes
Type 1 Diabetes
Type 1 Diabetes
A randomized, double-blind, Phase 3 study to investigate efficacy and safety of teplizumab compared with placebo in participants 1 to 25 years of age with recently diagnosed Stage 3 Type 1 Diabetes (T1D)